Infection Risk Factors
Cross-source consensus on Infection Risk Factors from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Other
Highlighted claims
- The study evaluates associations between infection risk and CRS, ICANS, neutropenia, hypogammaglobulinaemia, lymphopenia, and antimicrobial prophylaxis. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- CRS, ICANS, neutropenia, and lymphopenia are recorded both early after therapy and near infection events. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- Glucocorticoid exposure is measured as cumulative dexamethasone-equivalent dose across post-therapy and pre-infection windows. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- Hypogammaglobulinaemia is captured as a diagnosis with or without active intravenous immunoglobulin replacement. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- Haematological recovery is assessed using qualitative recovery patterns and quantitative immune-cell measures. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol